These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7621688

  • 1. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB, Lobo RA.
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [Abstract] [Full Text] [Related]

  • 2. Carbohydrate metabolism before and after Norplant removal.
    Konje JC, Odukoya OA, Otolorin EO, Ewings PD, Ladipo OA.
    Contraception; 1992 Jul; 46(1):61-9. PubMed ID: 1424624
    [Abstract] [Full Text] [Related]

  • 3. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I, Lähteenmäki P, Mishell DR, Alvarez F, Diaz S, Ranta S, Grozinger C, Lacarra M, Brache V, Pavez M, Nash H, Stern J.
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [Abstract] [Full Text] [Related]

  • 4. The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions.
    Shamma FN, Rossi G, HajHassan L, Penzias AS, Connoly-Diamond M, Jones E, Diamond MP.
    Fertil Steril; 1995 Apr; 63(4):767-72. PubMed ID: 7890060
    [Abstract] [Full Text] [Related]

  • 5. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
    Anwar M, Soejono SK, Maruo T, Abdullah N.
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
    [Abstract] [Full Text] [Related]

  • 6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 8. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [Abstract] [Full Text] [Related]

  • 9. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 10. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T, Lindheim SR, Duffy DM, Vijod MA, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [Abstract] [Full Text] [Related]

  • 11. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 12. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K, Viegas OA, Loke DF, Ratnam SS.
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [Abstract] [Full Text] [Related]

  • 13. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the effects of NORPLANT capsules and NORPLANT-2 rods on clinical chemistry: metabolic changes.
    Singh K, Viegas OA, Ratnam SS.
    Ann Acad Med Singap; 1990 Nov; 19(6):833-6. PubMed ID: 2130749
    [Abstract] [Full Text] [Related]

  • 15. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 16. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 17. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK, Ramadan M, el-Sawi M, Mehanna MT, Khamis Y, Marzouk S.
    Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
    [Abstract] [Full Text] [Related]

  • 18. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY, Yang YS, Tseng LH, Ko TM, Hsu MC, Chuang SM.
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [Abstract] [Full Text] [Related]

  • 19. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism.
    Konje JC, Otolorin EO, Ladipo OA.
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):15-9. PubMed ID: 1733189
    [Abstract] [Full Text] [Related]

  • 20. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.